Mark Christanson
Fondatore presso NEUROONE MEDICAL TECHNOLOGIES CORPORATION
Patrimonio netto: 235 754 $ in data 30/06/2024
Profilo
Mark Christanson is the founder of NeuroOne Medical Technologies Corp., which was founded in 2009.
He held the title of Director-Business Development at the company.
He is currently working at Neuroone, Inc. as the Vice President-Business Development & Marketing since 2016.
Mr. Christanson has previously worked at Robert Half, Inc. as the Head-Business Development from 2009 to 2012, at Cortec Corp.
as the Manager-North American Sales from 2013 to 2016, and at PMT Corp.
(United States) as the Manager-Regional Sales from 2009 to 2012.
He completed his undergraduate degree at Augsburg College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 30/06/2024 | 294 692 ( 1.06% ) | 235 754 $ | 30/06/2024 |
Posizioni attive di Mark Christanson
| Società | Posizione | Inizio |
|---|---|---|
| NEUROONE MEDICAL TECHNOLOGIES CORPORATION | Fondatore | 20/08/2009 |
Neuroone, Inc.
 Neuroone, Inc. Hospital/Nursing ManagementHealth Services Neuroone, Inc. operates neurological care centers to treat disorders of the brain and spinal cord. It is a technology platform adds significant value both for payors and patients specifically in the way the company manage treatments for epilepsy, Parkinson’s disease and other neurological disorders. The company was founded in 2016 and is headquartered in Minnetonka, MN. | Vendite & Marketing | 01/12/2016 |
Precedenti posizioni note di Mark Christanson
| Società | Posizione | Fine |
|---|---|---|
Cortec Corp.
 Cortec Corp. Chemicals: Major DiversifiedProcess Industries Cortec Corp. engages in the manufacture and supply of corrosion protection inhibitors. It provides corrosion-control products for commercial and consumer applications. It operates through the vapor phase corrosion inhibitor and migrating corrosion inhibitor product lines. The company was founded by Boris Miksic in 1977 and is headquartered in Saint Paul, MN. | Vendite & Marketing | 01/12/2016 |
PMT Corp. (United States)
 PMT Corp. (United States) Medical SpecialtiesHealth Technology PMT Corp. is a private company based in Chanhassen, MN. The company develops medical devices and instruments. | Vendite & Marketing | 01/02/2012 |
| ROBERT HALF INTERNATIONAL, INC | Corporate Officer/Principal | 01/02/2012 |
Formazione di Mark Christanson
| Augsburg College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ROBERT HALF INTERNATIONAL, INC | Commercial Services |
| NEUROONE MEDICAL TECHNOLOGIES CORPORATION | Health Technology |
| Aziende private | 3 |
|---|---|
Cortec Corp.
Cortec Corp. Chemicals: Major DiversifiedProcess Industries Cortec Corp. engages in the manufacture and supply of corrosion protection inhibitors. It provides corrosion-control products for commercial and consumer applications. It operates through the vapor phase corrosion inhibitor and migrating corrosion inhibitor product lines. The company was founded by Boris Miksic in 1977 and is headquartered in Saint Paul, MN. | Process Industries |
Neuroone, Inc.
Neuroone, Inc. Hospital/Nursing ManagementHealth Services Neuroone, Inc. operates neurological care centers to treat disorders of the brain and spinal cord. It is a technology platform adds significant value both for payors and patients specifically in the way the company manage treatments for epilepsy, Parkinson’s disease and other neurological disorders. The company was founded in 2016 and is headquartered in Minnetonka, MN. | Health Services |
PMT Corp. (United States)
PMT Corp. (United States) Medical SpecialtiesHealth Technology PMT Corp. is a private company based in Chanhassen, MN. The company develops medical devices and instruments. | Health Technology |
- Borsa valori
- Insiders
- Mark Christanson
